Status:
COMPLETED
Nasal Steroids in Controlled Glaucoma
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Glaucoma Research Society of Canada
Conditions:
Intraocular Pressure
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Patients that have consented to participate in the study will be randomly assigned to one of two groups: control group or nasal steroid group. Patients in the control group will receive normal saline ...
Detailed Description
Systemic and topical ophthalmic steroids have long been associated with ocular effects, such as glaucoma or cataracts. Periocular steroid injections and steroids applied to periocular skin have also b...
Eligibility Criteria
Inclusion
- Inclusion criteria included the following:
- age 18 to 85 years inclusive
- OHT or mild to moderate POAG with cup-disc ratio of less than 0.8 vertically and mean deviation of less than -12.00 dB on Humphrey perimetry
- well controlled disease defined by IOP being at target and no visual field or disc progression for a minimum of 6 months
- Exclusion criteria included the following:
- any form of steroid medication use within the last 6 weeks
- previous intra-ocular or refractive surgery
- no light perception vision.
- Patients with or without rhinitis (allergic/ non-allergic/ mixed), with rhinitis defined as allergies and/ or nasal congestion present for greater than one year, were eligible.
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00775489
Start Date
January 1 2010
End Date
July 1 2010
Last Update
January 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Toronto; Toronto Western Hospital
Toronto, Ontario, Canada